ASGE and AstraZeneca Announce Partnership to Further GI Clinical Research through CORI.Business Editors, Health & Medical Writers Digestive Disease All diseases that pertain to the gastrointestinal tract are labelled as digestive diseases. This includes diseases of the esophagus, stomach, first, second and third part of the duodenum, jejunum, ileum, the ileo-cecal complex, large intestine (ascending, transverse and descending Week 2000 SAN DIEGO--(BUSINESS WIRE)--May 22, 2000 The American Society for Gastrointestinal Endoscopy The American Society for Gastrointestinal Endoscopy, or ASGE, is a professional organization of physicians dedicated to improving endoscopy. The ASGE is made up largely of gastroenterologists from the United States. (ASGE ASGE American Society for Gastrointestinal Endoscopy (Oak Brook, IL) ASGE Associate of Science in General Education ), and AstraZeneca, the world leader in GI pharmaceuticals, today announced the formation of a Premiere Partnership to further the ASGE's mission to expand and enhance GI research through its Clinical Outcomes Research Initiative (CORI). Currently CORI captures 8,000 clinical data records each month from approximately 70 GI endoscopic en·do·scope n. An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach. en sites and more than 700 clinicians nationwide. With AstraZeneca's assistance, CORI will build upon the work completed to date to develop the largest, internationally renowned, clinical data repository A Clinical Data Repository (CDR) is a real-time database that consolidates data from a variety of clinical sources to present a unified view of a single patient. It is optimized to allow clinicians to retrieve data for a single patient rather than to identify a population of to support GI endoscopic research. The ASGE and AstraZeneca have signed a letter of intent to establish a long-term agreement to formalize a partnership which has been in the making for some time. "Our partnership with AstraZeneca has not happened overnight. We have been building this relationship informally for the last several years and are extremely pleased with our joint efforts to date. AstraZeneca has been a supporter of CORI every step of the way," stated Michael B. Kimmey, M.D., ASGE President-elect. Through the proposed alliance agreement, AstraZeneca will provide financial and operational support to assist with expansion of the CORI research repository, development of an internet-enabled technological infrastructure, and development of new GI research products and services, in an effort to better understand the relationship between GI endoscopy endoscopy Examination of the body's interior through an instrument inserted into a natural opening or an incision, usually as an outpatient procedure. Endoscopes include the upper gastrointestinal endoscope (for the esophagus, stomach, and duodenum), the colonoscope (for the and the quality of patient outcomes. "We have witnessed the significant progress that CORI has achieved with very few resources to date, and are duly impressed. We view this partnership as a means to build a far greater understanding of GI diseases and clinical outcomes than was ever thought possible," said Mark Mallon, AstraZeneca's Therapeutic Leader of Gastroenterology gastroenterology Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833. . Growing the research repository will provide physicians with access to a diverse pool of clinical research data to further the development of GI therapies and thereby improve the health of patients. "With AstraZeneca's support we will be able to grow the data repository and provide a richer data set for GI endoscopic research much quicker than would have been possible otherwise," said David Fleischer, M.D., Deputy Director of CORI. Tom McCourt, GI Product Manager, of AstraZeneca echoed these sentiments, "We expect the CORI data repository to become the de facto standard Hardware or software that is widely used, but not endorsed by a standards organization. Contrast with de jure standard. de facto standard - A widespread consensus on a particular product or protocol which has not been ratified by any official standards body, such as ISO, to support the conduct of clinical outcomes research associated with digestive diseases and procedures encountered by GI patients. We are very excited to be able to move our relationship with ASGE/CORI to this level." Over the next 60 days, ASGE/CORI hopes to finalize this relationship as well as a number of other preferred partner alliances being formed with endoscope endoscope, any instrument used to look inside the body. Usually consisting of a fiber-optic tube attached to a viewing device, endoscopes are used to explore and biopsy such areas as the colon and the bronchi of the lungs. manufacturers and GI software companies. "Our relationship with AstraZeneca will serve as a model for the type of relationships we will form with other commercial organizations." said David Lieberman, MD, Director of CORI. About CORI In 1995, the ASGE founded the Clinical Outcomes Research Initiative (CORI) as a national data repository for endoscopic research. The shared repository is designed to promote endoscopic research among GI physicians. CORI is a leading source of GI research information, receiving more than 8,000 patient clinical records from more than 700 physicians nationwide each month. CORI research data has been used to support more than 50 major research initiatives to date. CORI operates as a not-for-profit organization under the auspices of ASGE. For more information visit CORI's web-site: www.cori.org. About ASGE The American Society for Gastrointestinal Endoscopy (ASGE) represents more than 7,000 gastroenterologists, surgeons, and other digestive health specialists who are committed to furthering the knowledge of the diagnosis and treatment of GI disease through the appropriate use of endoscopic techniques. For more information visit their web site: www.asge.org. About AstraZeneca AstraZeneca (NYSE NYSE See: New York Stock Exchange :AZN AZN Asian ) is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of $15 billion and leading positions in sales of gastrointestinal, oncology, anesthesia including pain management, cardiovascular, central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) and respiratory products. In the U.S., AstraZeneca is a $7.4 billion healthcare business with approximately 9,500 employees. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion